Rhythm Pharmaceuticals, Inc. (RYTM) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist RA CAPITAL MANAGEMENT, LLC mit 5,422,312 Aktien. Weitere bedeutende Anteilseigner sind RA CAPITAL MANAGEMENT, L.P. und THIRD ROCK VENTURES LP.
In den letzten 12 Monaten haben Insider 57 Transaktionen in RYTM Aktien getätigt — 19 Käufe (im Wert von $3.32M) und 11 Verkäufe (im Wert von $2.56M). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
RYTM Insider-Beteiligungen
Größter Aktionär
RA CAPITAL MANAGEMENT, LLC
5,422,312 Aktien
Käufe (12 Monate)
19
$3.32M Wert
Verkäufe (12 Monate)
11
$2.56M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Ra Capital Management, Llc |
10 Percent Owner |
5,422,312 |
2019-10-18 |
|
| 2 |
Ra Capital Management, L.p. |
Officer |
4,568,464 |
2020-12-04 |
|
| 3 |
Third Rock Ventures Lp |
10 Percent Owner |
2,981,437 |
2018-09-04 |
|
| 4 |
Orbimed Advisors Llc |
10 Percent Owner |
2,750,079 |
2018-05-24 |
|
| 5 |
Foley Todd |
Director |
909,258 |
2021-03-16 |
|
| 6 |
Gottesdiener Keith Michael |
CEO & President |
207,877 |
2020-03-11 |
|
| 7 |
Smith Hunter C |
Chief Financial Officer |
91,401 |
2026-03-02 |
|
| 8 |
Meeker David P |
President and CEO |
71,900 |
2026-02-13 |
|
| 9 |
Desikan Nithya |
Chief Commercial Officer |
43,602 |
2020-09-01 |
|
| 10 |
Fiedorek Fred T. |
Chief Medical Officer |
25,000 |
2018-02-16 |
|
| 11 |
Lee Jennifer Kayden |
EVP, Head of North America |
21,650 |
2026-02-13 |
|
| 12 |
Garfield Alastair |
Chief Scientific Officer |
16,650 |
2026-02-13 |
|
| 13 |
Shulman Joseph |
Chief Technical Officer |
15,000 |
2026-02-13 |
|
| 14 |
Mathers Edward T |
Director |
14,168 |
2026-03-16 |
|
| 15 |
Van Der Ploeg Leonardus H.t. |
Chief Scientific Officer |
13,611 |
2019-06-03 |
|
| 16 |
Manning Linda Shapiro |
Chief Medical Officer |
12,500 |
2022-02-11 |
|
| 17 |
Cramer Pamela J. |
Chief Human Resources Officer |
11,650 |
2026-02-13 |
|
| 18 |
Exter Neil |
Director |
10,000 |
2018-06-08 |
|
| 19 |
Stewart Murray |
Chief Medical Officer |
9,375 |
2021-02-16 |
|
| 20 |
Popovits Kimberly J |
Director |
6,808 |
2026-04-03 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-01 |
Mazabraud Yann |
EVP, Head of International |
Optionsausübung (Verkauf) |
2,500 |
- |
- |
| 2026-04-01 |
Popovits Kimberly J |
Director |
RSU-Zuteilung |
6,808 |
- |
- |
| 2026-04-01 |
Popovits Kimberly J |
Director |
Unbekannt |
- |
- |
- |
| 2026-03-12 |
Mathers Edward T |
Director |
Sonstige (Kauf) |
4,199 |
- |
- |
| 2026-03-04 |
German Christopher Paul |
Corporate Controller & CAO |
Informierter Verkauf |
5,614 |
$89.56 |
$502.79K |
| 2026-03-02 |
Mazabraud Yann |
EVP, Head of International |
RSU-Zuteilung |
35,000 |
$94.94 |
$3.32M |
| 2026-03-02 |
Mathers Edward T |
Director |
Sonstige (Kauf) |
4,198 |
- |
- |
| 2026-03-01 |
German Christopher Paul |
Corporate Controller & CAO |
Optionsausübung (Verkauf) |
1,162 |
- |
- |
| 2026-03-02 |
Smith Hunter C |
Chief Financial Officer |
Optionsausübung (Verkauf) |
6,099 |
$6.80 |
$41.47K |
| 2026-02-19 |
Smith Hunter C |
Chief Financial Officer |
Informierter Verkauf |
585 |
$103.28 |
$60.42K |
| 2026-02-17 |
Smith Hunter C |
Chief Financial Officer |
Informierter Verkauf |
200 |
$103.84 |
$20.77K |
| 2026-02-14 |
Mazabraud Yann |
EVP, Head of International |
Optionsausübung (Verkauf) |
10,000 |
- |
- |
| 2026-02-11 |
Garfield Alastair |
Chief Scientific Officer |
RSU-Zuteilung |
16,650 |
- |
- |
| 2026-02-11 |
Shulman Joseph |
Chief Technical Officer |
RSU-Zuteilung |
15,000 |
- |
- |
| 2026-02-11 |
Cramer Pamela J. |
Chief Human Resources Officer |
RSU-Zuteilung |
11,650 |
- |
- |
| 2026-02-11 |
Lee Jennifer Kayden |
EVP, Head of North America |
RSU-Zuteilung |
21,650 |
- |
- |
| 2026-02-11 |
Mazabraud Yann |
EVP, Head of International |
RSU-Zuteilung |
23,350 |
- |
- |
| 2026-02-11 |
Meeker David P |
President and CEO |
RSU-Zuteilung |
71,900 |
- |
- |
| 2026-02-11 |
German Christopher Paul |
Corporate Controller & CAO |
RSU-Zuteilung |
5,215 |
- |
- |
| 2026-02-12 |
Smith Hunter C |
Chief Financial Officer |
Informierter Verkauf |
100 |
$100.10 |
$10.01K |
| 2026-02-11 |
Smith Hunter C |
Chief Financial Officer |
RSU-Zuteilung |
25,000 |
- |
- |
| 2026-02-10 |
Smith Hunter C |
Chief Financial Officer |
Informierter Verkauf |
100 |
$104.76 |
$10.48K |
| 2026-02-05 |
Smith Hunter C |
Chief Financial Officer |
Informierter Verkauf |
3,381 |
$106.06 |
$358.6K |
| 2026-02-04 |
Smith Hunter C |
Chief Financial Officer |
Informierter Verkauf |
747 |
$107.67 |
$80.43K |
| 2026-02-01 |
Garfield Alastair |
Chief Scientific Officer |
RSU-Steuereinbehalt |
2,026 |
$108.99 |
$220.81K |
